Zymeworks Closes $3.2 Mln round
Zymeworks Inc. , a Vancouver-based antibody-based therapeutics startup, has raised C$3.2 million in new VC funding led by return backer CTI Life Sciences Fund.
29 June 2010•2 mins read
Zymeworks Inc. , a Vancouver-based antibody-based therapeutics startup, has raised C$3.2 million in new VC funding led by return backer CTI Life Sciences Fund.
